Use of inhaled corticosteroids in pediatric asthma

Pediatric Pulmonology

Volumn 24, Issue SUPPL. 15, 1997, Pages 27-33

  Bisgaard, Hans ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Beneficial effects; Inhaled corticosteroids; Pediatric asthma; Treatment guidelines

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; ANTIASTHMATIC AGENT;

ADOLESCENT; ADULT; ASTHMA; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DOSE RESPONSE; GROWTH RETARDATION; HUMAN; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MUSCLE HYPERTROPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCHOOL CHILD; WHEEZING; AIRWAY RESISTANCE; BODY HEIGHT; CHILD; DRUG EFFECT; INFANT; LUNG VOLUME; PRESCHOOL CHILD; REVIEW;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AIRWAY RESISTANCE; ANTI-ASTHMATIC AGENTS; ASTHMA; BODY HEIGHT; BRONCHIAL HYPERREACTIVITY; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LUNG VOLUME MEASUREMENTS;

EID: 0031227579     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199709)15+<27::AID-PPUL7>3.0.CO;2-O     Document Type: Conference Paper

References (54)

1. Price JF, Weller PH. Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study). Respir Med. 1995; 89:363-368.
2. Edmunds AT, Goldberg RS, Duper B, Devichand P, Follows RM. A comparison of budesonide 800 μg and 400 μg via Turbohaler with disodium cromoglycate via Spinhaler for asthma prophylaxis in children. Br J Clin Res. 1994; 5:11-23.
3. Meltzer EO, Orgel HA, Ellis EF, Eigen HN, Hemstreet MP. Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma. J Allergy Clin Immunol. 1992; 90:2-11.
4. van Essen-Zandvliet E, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis. 1992; 146:547-554.
5. Verberne AAPH, Frost C, Bogaard JM, Kerrebijn KF. One year treatment with salmeterol compared to inhaled corticosteroid in children with mild to moderate asthma (abstract). Am J Respir Crit Care Med. 1996; 153:A408.
6. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med. 1994; 88:373-381.
7. Scheffer AL, LaForce C, Chervinsky P, Pearlman D, Schaberg A. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. J Fam Pract. 1996; 42:369-375.
8. Martinez FD, Wright AL, Taussig LM, Holberg C, Halonen M, Morgan WJ, and the Group Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med. 1995; 332:133-138.
9. Tager IB, Hanrahan JP, Tosteson TD, Castille RG, Brown RW, Weiss ST, Speizer FE. Lung function, pre- and post-natal smoke exposure, and wheezing in the first year of life. Am Rev Respir Dis. 1993; 147:811-817.
10. Sont JK, Han J, van Krieken JM, Evertse CE, Hooijer R, Willems LN, Sterk PJ. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax. 1996; 51:496-502.
11. Burrows B, Knudson RJ, Lebowitz MD. The relationship of childhood respiratory illness to adult obstructive airway disease. Am Rev Respir Dis. 1977; 115:751-760.
12. Kerribijn KF, Fioole AC, van Bemtveld RDW. Lung function in asthmatic children after a year or more with out symptoms or treatment. Br Med J. 1978; i:886-888.
13. Cade JF, Pain MC. Pulmonary function during clinical remission of asthma. How reversible is asthma? Aust N Z J Med. 1983; 3:545-551.
14. Mosfeldt-Laursen E, Kaae-Hansen K, Backer V, Bach-Mortensen N, Prahl P, Koch C. Pulmonary function in adolescents with childhood asthma. Allergy. 1993; 48:267-272.
15. Godden DJ, Ross S, Abdalla M. McMurray D, Douglas A, Oldman D, Friend JAR, Legge JS, Douglas JG. Outcome of wheeze in childhood. Am J Respir Crit Care Med. 1994; 149:106-112.
16. Martin AJ, Landau LI, Phelan PD. Lung function in young adults who had asthma in childhood. Am Rev Respir Dis. 1980; 122: 609-616.
17. Kelly WJ, Hudson I, Raven J, Phelan PD, Pain MC, Olinsky A. Childhood asthma and adult lung function. Am Rev Respir Dis. 1988; 138:26-30.
18. Backer V, Ulrik CS. Development of lung function in relation to increased degree of bronchial responsiveness. J Asthma. 1992; 29:331-341.
19. Borsboom GJJM, van Pelt W, Quanjer PH. Pubertal growth curves of ventilatory function: relationship with childhood respiratory symptoms. Am Rev Respir Dis. 1993; 147:372-378.
20. Sherrill D, Sears MR, Lebowitz MD, Holdaway MD, Hewitt CJ, Flannery EM, Herbison GP, Silva PA. The effects of airway hyperresponsiveness, wheezing and atopy on longitudinal pulmonary function in children: a 6-year follow-up study. Pediatr Pulmonol. 1992; 13:78-85.
21. Weiss ST, Tosteson TD, Segal MR, Tager IB, Redline S, Speizer FE. Effects of asthma on pulmonary function in children. Am Rev Respir Dis. 1992; 145:58-64.
22. Gold DR, Wypij D, Wang X, Speizer FE, Pugh M, Ware JH, Ferris BG, Dockery DW. Gender- and race-specific effects of asthma and wheeze on level and growth of lung function in children in six US cities. Am J Respir Crit Care Med. 1994; 149: 1198-1208.
23. Peat JK, Woolcock, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis. 1987; 70:171-179.
24. Ulrik CS, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax. 1992; 47:14-18.
25. Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med. 1994; 150:629-634.
26. Sears MR, Taylor DR, Print CG, Lake DC, Li QQ, Flannery EM, Yates DM, Lucas MK, Herbison GP. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet. 1990; 336:1391-1396.
27. van Schayck CP, Graafsma SJ, Visch MB, Dompeling E, vanWeel C, van Herwaarden CL. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J Allergy Clin Immunol. 1990; 86:793-800.
28. McFadden ER Jr. The beta 2-agonist controversy revisited. Ann Allergy Asthma Immunol. 1995; 75:173-176.
29. Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroids, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. 1992; 97:32-42.
30. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis. 1992; 145:890-899.
31. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, Holgate ST. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis. 1992; 145:669-674.
32. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis. 1993; 147:697-704.
33. Wilson JW, Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy. 1997; 27:363-371.
34. Cutz E, Levison H, Cooper DM. Ultrastructure of airways in children with asthma. Histopathology. 1978; 2:407-421.
35. Saetta M, DiStefano A, Maestrelli P, DeMarzo N, Milani GF, Pivirotto F, Mapp CE, Fabbri LM. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate. Am Rev Respir Dis. 1992; 145:160-168.
36. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijarvi A, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 1994; 331:700-705.
37. Overbeck SE, Kerstjens HAM, Bogaard JM, Mulder PGH, Postma DS, and the Dutch Chronic Non-specific Lung Disease Study Group. Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? Chest. 1996; 110:35-41.
38. Panhuysen CIM, Vonk JM, Koëter GH, Schouten JP, van Altena R, Bleecker ER, Postma DS. Adult patients may outgrow their asthma. Am J Respir Crit Care Med. 1997; 155:1267-1272.
39. König P, Schaffer J. The effect of drug therapy on long-term outcome of childhood asthma: a possible preview of the international guidelines. J Allergy Clin Immunol. 1996; 98:1103-1111.
40. Selroos O, Pietinalho A, Lofroos AB, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest. 1995; 108:1228-1234.
41. Warner JO. Asthma treatment in children and adolescents. Eur Respir Rev. 1997; 7:15-18.
42. Doull IJM, Freezer NJ, Holgate ST. Growth of pre-pubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med. 1995; 151:1715-1719.
43. Derom E, Van Schoor J, Vincken W, Kuybrechts M, Remgård P, Persson M, Pauwels R. A comparison of the systemic activity of two doses of inhaled fluticasone propionate and budesonide in asthmatics patients. Eur Respir J. 1996; 9(Suppl 23):162s.
44. Lönnebo A, Grahnen A, Jansson B, Brundin RM, Ling-Andersson A, Eckernäs SÅ. An assessment of the systemic effects of single and repeated doses of inhaled fluticasone dipropionate and inhaled budesonide in healthy volunteers. Eur J Clin Pharmacol. 1996; 49:459-463.
45. Clark DJ, Grove A, Cargill RI, Lipworth BJ. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax. 1996; 51:262-266.
46. Boorsma M, Andersson N, Larsson P, Ullman A. Assessment of the relative systemic potency of inhaled fluticasone and budesonide. Eur Respir J. 1996; 9:1427-1432.
47. Ninan TK, Russell G. Asthma, inhaled corticosteroid treatment, and growth. Arch Dis Child. 1992; 67:703-705.
48. Martin AJ, McLennan LA, Landau LI, Phelan PD. The natural history of childhood asthma to adult life. Br Med J. 1980; 280: 1397-1400.
49. Allen DB, Mullen M, Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol. 1994; 93:967-976.
50. MacKenzie CA, Weinberg EG, Tabachnik E, Taylor M, Havnen J, Crescenzi K. A placebo controlled trial of fluticasone propionate in asthmatic children. Eur J Pediatr. 1993; 152:856-860.
51. Pedersen S, Hansen OR. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol. 1995; 95:29-33.
52. Geddes DM. Inhaled corticosteroids: benefits and risks (editorial). Thorax. 1992; 47:404-407.
53. Lipworth B. Clinical pharmacology of corticosteroids in bronchial asthma. Pharmacol Ther. 1993; 58:173-209.
54. Haahtela T. Airway remodelling takes place in asthma-what are the clinical implications? (editorial). Clin Exp Allergy. 1997; 27: 351-353.